MichaelYuSyMD

Clinical Trials

• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) Start of enrollment: 2021 Mar 17

  Active, not recruiting

  Phase 3

• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) Start of enrollment: 2020 Dec 03

  Active, not recruiting

  Phase 3

• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2017 Mar 24

  Completed

  Phase 3

• Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients Start of enrollment: 2019 Feb 14

  Completed

  Phase 3

• CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD) Start of enrollment: 2021 Apr 28

  Enrolling by invitation

• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Start of enrollment: 2022 Aug 30

  Recruiting

  Phase 3

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis Start of enrollment: 2023 Dec 13

  Recruiting

  Phase 3

• Study to Evaluate Efficacy When Transitioning From a Current Disease Modifying Therapy (DMT) to Ublituximab Start of enrollment: 2023 Jun 13

  Recruiting

  Phase 3

• Join now to see all